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INTRODUCTION
Epilepsy is a common neurological disorder that is frequently
characterised by recurrent, unprovoked seizures that result from
excessive and hypersynchronous electrical discharges in the brain.
Depending on the location and extent of the abnormal electrical
activity in the brain, epileptic seizures can manifest in many
different ways, which can include temporary loss of consciousness,
or abnormal motor activity that can range from minor involuntary
movements to whole body convulsions. Many different epilepsy
syndromes are recognised, each of which affects the nervous
system in distinct ways, and in which seizures are prominent
phenotypic components (Reid et al., 2009). Seizures can be either
localized to specific parts of the brain, or distributed more broadly
as generalized seizures. Epileptic seizures can affect people of all
ages. They can occur in the absence of structural brain
abnormalities or be a manifestation of an underlying brain lesion,
such as a brain tumour or changes attributable to a head injury.
Genetic factors also play important roles in many forms of epilepsy
(Reid et al., 2009). A wide range of structurally diverse anti-epileptic
drugs is currently available for treatment of this disorder (Stafstrom,
2010). These drugs act in a variety of distinct ways. For example,
benzodiazepines act as direct agonists of GABAA receptors, whereas
carbamazepine and lamotrigine block sodium (Na+) and calcium
(Ca2+) channels, the normal opening of which enables the firing of
neuronal action potentials in response to excitatory
neurotransmitters. Moreover, valproic acid (VPA) has been shown
to inhibit the activities of histone deacetylases and GABA
transaminase, as well as to reduce the production of
phosphoinositides (Nalivaeva et al., 2009; Chang et al., 2012), so
its therapeutic effects might result from a combination of these
modes of action. Despite the wide variety of available treatments,
approximately 30% of people with epilepsy fail to respond
satisfactorily to first-line anti-epileptic drugs (Remy and Beck,
2006). Furthermore, many prescribed anti-epileptic drugs exhibit
substantial side effects (Cramer et al., 2010). There is, therefore,
an important unmet clinical need for new antiepileptic therapeutics
with more specific mechanisms of action, fewer side effects and
increased potency.
In order to develop new antiepileptics and understand the
pathogenetic mechanisms underlying seizure disorders, animal
models of epilepsy are invaluable. Pharmacological and genetic
models of epilepsy have been developed in rodents, using known
convulsant agents to induce seizures, as well as through the
phenotypic analysis of mutations that cause seizures (Löscher,
2011). Rodent models have been used extensively both for
elucidating seizure mechanisms and characterising the mechanisms
of action of anti-epileptic drugs. However, the relatively high costs
and labour-intensive nature of drug discovery work using rodents
limit their usefulness as organisms in which large numbers of
compounds can be efficiently screened to identify compounds with
anticonvulsant activities. Consequently, seizure models have been
developed in a range of non-mammalian organisms that are more
amenable to high-throughput analysis (Baraban, 2007). Among
these species, the zebrafish is emerging as a pre-eminent model
vertebrate for the in vivo analysis of many developmental and
disease mechanisms. Moreover, within the last few years, the
usefulness of this organism for in vivo drug discovery has become
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SUMMARY
The availability of animal models of epileptic seizures provides opportunities to identify novel anticonvulsants for the treatment of people with
epilepsy. We found that exposure of 2-day-old zebrafish embryos to the convulsant agent pentylenetetrazole (PTZ) rapidly induces the expression
of synaptic-activity-regulated genes in the CNS, and elicited vigorous episodes of calcium (Ca2+) flux in muscle cells as well as intense locomotor
activity. We then screened a library of ~2000 known bioactive small molecules and identified 46 compounds that suppressed PTZ-induced transcription
of the synaptic-activity-regulated gene fos in 2-day-old (2 dpf) zebrafish embryos. Further analysis of a subset of these compounds, which included
compounds with known and newly identified anticonvulsant properties, revealed that they exhibited concentration-dependent inhibition of both
locomotor activity and PTZ-induced fos transcription, confirming their anticonvulsant characteristics. We conclude that this in situ hybridisation
assay for fos transcription in the zebrafish embryonic CNS is a robust, high-throughput in vivo indicator of the neural response to convulsant treatment
and lends itself well to chemical screening applications. Moreover, our results demonstrate that suppression of PTZ-induced fos expression provides
a sensitive means of identifying compounds with anticonvulsant activities.
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increasingly apparent. Several recent studies have demonstrated
that the zebrafish is particularly well suited to the analysis of
epilepsy mechanisms and anti-epileptic drug discovery (Baraban
et al., 2005; Berghmans et al., 2007; Hortopan et al., 2010a;
Hortopan et al., 2010b; Stewart et al., 2012). At 7 days of age, the
free-swimming, independently feeding zebrafish larva exhibits
seizures when treated with chemical convulsants (Baraban et al.,
2005; Winter et al., 2008), and these seizures can be ameliorated
by administration of known anti-epileptic drugs (Baraban et al.,
2005; Berghmans et al., 2007). Other behavioural phenotypes can
also be readily analysed in embryos, larvae, or juvenile or adult
zebrafish by immersion in fish water containing neuroactive
compounds such as addictive, anxiolytic or anxiogenic agents
(Darland and Dowling, 2001; Kokel et al., 2010; Cachat et al., 2010;
Cachat et al., 2011; Steenbergen et al., 2011; Norton and Bally-Cuif,
2010). One of the key experimental advantages of the zebrafish
stems from the transparency of its embryo, which facilitates three-
dimensional analysis of gene expression patterns using whole-
mount in situ hybridisation. We took advantage of this technique
to establish a robust and sensitive gene-expression-based in vivo
assay for seizures in 2-day-old [2 days post-fertilisation (dpf)]
zebrafish embryos. We then utilised this assay in a medium-
throughput screen of a collection of 2000 bioactive small molecules
to identify a subset of compounds with previously unknown
anticonvulsant activities. This group of compounds includes
molecules that could represent new candidate therapeutics for
treating epilepsy.
RESULTS
Pharmacological induction of convulsions in zebrafish embryos
Exposure of 7 dpf zebrafish larvae to chemical convulsants such
as pentylenetetrazole (PTZ) induces seizures that exhibit many
of the features of epilepsy, including clonic-like convulsions and
ictal-like electrographic discharges (Baraban et al., 2005; Winter
et al., 2008; Berghmans et al., 2007). In both rodents and larval
zebrafish, induction of seizures is accompanied by robust
expression of the synaptic-activity-dependent neuroprotective
gene fos in the brain (Zhang et al., 2002; Baraban et al., 2005). By
7 dpf, zebrafish larvae swim fast, respond to a wide variety of
sensory stimuli and exhibit a broad range of behaviours. However,
by 7 dpf the larval integument is heavily pigmented and the
nervous system is highly complex, which makes the analysis of
CNS-specific gene expression patterns challenging. By contrast,
2 dpf embryos have a simple, transparent integument, which
makes them amenable to whole-mount analysis of gene expression
patterns in the developing CNS. Furthermore, by 2 dpf, embryos
exhibit locomotor responses to extrinsic mechanical stimuli,
implying the existence of neural circuits that could mediate
locomotor responses of embryos to treatment with seizure-
inducing chemicals. Previous studies have demonstrated that
exposure of zebrafish larvae to PTZ elicited concentration-
dependent increases in locomotor activity (Berghmans et al.,
2007). We analysed the locomotor behaviour of 4 dpf larvae
exposed to concentrations of PTZ ranging from 1.25 mM to 80
mM. Robust, concentration-dependent increases in locomotor
activity were observed in response to treatment with PTZ, which
was greatest after exposure to 20 mM PTZ (Fig. 1A). This
concentration of PTZ was selected for all subsequent experiments.
Evidence suggests that convulsants such as PTZ elicit seizures by
inhibiting the GABAA receptor (Huang et al., 2001). In situ
hybridisation analysis of 48 hpf embryos for expression of the
GABAA receptor subunit genes gabra1 and gabrg2 revealed
widespread expression of both genes in the brain (Fig. 1B),
implying the existence of large numbers of GABA-responsive
neurons in the CNS at this early stage of development. Consistent
with these observations, treatment of 48 hpf embryos with 20 mM
PTZ also induced a robust increase in locomotor activity
characteristic of seizure induction (Fig. 1C, panel 1). To
characterise the PTZ-induced increase in locomotor activity
further, we microinjected a muscle-specific transgene encoding
the fluorescent calcium reporter GCaMP-3 into embryos at the
one-cell stage. 50 hpf embryos that transiently expressed GCaMP-
3 in muscle cells were then exposed to PTZ. Within 5 minutes of
exposure, intense muscular contractions could be readily detected
as robust, transient increases in GCaMP-3 fluorescence (Fig. 1C),
each of a duration of approximately 10 seconds, with an amplitude
up to five times that of baseline fluorescence and separated by
longer periods of relaxation (also see supplementary material
Movie 1). These spasms are characteristic features of clonic
seizures, indicating that PTZ induces neuromuscular convulsions
in 2-day-old zebrafish embryos that are similar to those observed
in some people with epilepsy.
A programme of seizure-associated gene expression in the CNS
and muscle of convulsant-treated 2-day-old zebrafish embryos
Having established that convulsions could be reliably induced in
2-day-old zebrafish embryos by exposure to the seizure-inducing
chemical PTZ, we sought to determine whether exposure to
convulsant elicited a corresponding programme of seizure-
associated gene expression. First, we investigated whether the
synaptic-activity-regulated gene fos was induced by exposure of 2-
day-old embryos to PTZ and another GABAA receptor inhibitor,
picrotoxin. Analysis of embryos after 30, 60 or 90 minutes of
treatment with either of these convulsants resulted in the induction
of fos transcripts in an intricate pattern of multiple discrete domains
within the ventral telencephalon, ventral diencephalon, hindbrain,
spinal cord and trunk muscle. Expression of fos was detectable in
the brain within 30 minutes of administering either PTZ or
picrotoxin, and had increased by 60 and 90 minutes after initial
administration (Fig. 2A). Closer inspection of the expression
domains of fos revealed that the robust induction of fos by PTZ in
the forebrain is restricted to two distinct territories: the ventral
telencephalon, including the subpallium, and the ventral
diencephalon, encompassing the preoptic area, posterior
tuberculum and hypothalamus (Fig. 2B). Taken together, these
results confirmed that the induction of fos expression in specific
regions of the developing CNS and trunk muscle of 2-day-old
zebrafish embryos after treatment with convulsant compounds is
a robust transcriptional response, consistent with the initiation of
seizures in the CNS and the onset of convulsions in the trunk
musculature. In order to determine whether PTZ- and picrotoxin-
mediated induction of fos expression in these domains could be
suppressed by a known anticonvulsant, we exposed embryos to the
anti-epileptic drug sodium valproate (VPA) and either PTZ or
picrotoxin, which resulted in the complete suppression of fos
expression (Fig. 2C).
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Previous studies of the transcriptional consequences of exposing
in vitro cultured neurons to convulsants and other inducers of
synaptic activity have demonstrated that a broad programme of
gene expression is elicited, components of which might perform
neuroprotective functions that limit neuronal depolarization and
help prevent calcium influxes reaching excitotoxic levels (Greer and
Greenberg, 2008). Among these genes, neuroprotective functions
are indicated for the bHLH-PAS-domain-containing transcription
factor gene Npas4 and the neurotrophic factor BDNF (Lin et al.,
2008; Greenberg et al., 2009). When expression of the zebrafish
orthologues of these two genes was analysed by whole-mount in
situ hybridisation, both npas4 and bdnf transcripts were induced
in the ventral telencephalon and diencephalon of PTZ-treated
embryos, in patterns that are similar to that of fos (Fig. 3). 3 dpf
zebrafish embryos that are homozygous for the recessive mind
bomb mutation were previously shown to exhibit seizure behaviour
and aberrantly increased expression of a close relative of the
endogenous anti-convulsant and anxiolytic Neuropeptide Y gene,
pyya (Hortopan et al., 2010a). Interestingly, we also observed that
PTZ treatment increased pyya expression within the CNS of 50
hpf wild-type embryos, which was most readily apparent within
the posterior hindbrain (Fig. 3).
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Fig. 1. Treatment of embryos and larvae with the GABA pathway inhibitor pentylenetetrazole induces convulsions that are characterised by increased
locomotor activity and calcium influx into muscle cells. (A)4 dpf larvae were exposed to 1.25, 2.5, 5, 10, 20, 40 or 80 mM PTZ for 10 minutes, then movements
were recorded over the next 10 minutes. Values are given as means (n4); error bars indicate s.e.m. ***Significantly different (P<0.001) from untreated embryos,
using one-way ANOVA with Dunnett’s post-test. Representative traces of movements after exposure to each PTZ concentration lie beneath each corresponding
value for PTZ concentration in the histogram. Black, green and red traces indicate swimming speeds of 0-1.5, 1.5-6 and >6 mm/second, respectively. (B)In situ
hybridisation analysis reveals strong expression of GABAA receptor component genes gabra1 and gabrg2 throughout the brain of 50 hpf embryos. (C)Induction
of convulsions in embryos by exposure to PTZ. Panel 1: representative traces of locomotor activity of 48 hpf embryos untreated (–PTZ) and exposed to 20 mM
PTZ (+PTZ). Black, green and red traces indicate swimming speeds of 0-1.5, 1.5-6 and >6 mm/second, respectively. Panels 2, 3 and 4: live confocal imaging of
GCaMP-3 fluorescence in the muscle of a 50 hpf zebrafish embryo transiently expressing a mylz2:GCaMP3 reporter transgene. Images are taken from a movie
after 5 minutes of exposure to 20 mM PTZ, before (Panel 2), during (Panel 3) and after (Panel 4) a single convulsion. Panel 5: graph of GCaMP-3 fluorescence from
the embryo in Panels 2-4, over a period in which two consecutive convulsions occurred.
D
ise
as
e 
M
od
el
s &
 M
ec
ha
ni
sm
s  
    
   D
M
M
An in situ hybridisation screen of a library of bioactive small
molecules for compounds with anti-convulsant activity in
zebrafish embryos
Our results indicated that a programme of CNS-specific and
muscle-specific gene expression accompanies the induction of
neuromuscular convulsions by PTZ in 2-day-old embryos, and that
this could be suppressed by co-administration of the known
anticonvulsant VPA, thus providing a robust method of monitoring
induction and suppression of convulsion-associated synaptic
activity in the CNS. Of the genes analysed, fos was the most
sensitive indicator of seizure onset. We therefore developed a high-
throughput in situ hybridisation assay for fos transcription as the
basis for identifying potential anti-convulsants, in a screen of 2000
known bioactive compounds in the Microsource Spectrum
Collection. Embryos were first exposed to these compounds in
96-well plates, then PTZ was added, after which samples were fixed
and analysed for expression of fos by whole-mount in situ
hybridisation. A total of 46 compounds were identified that caused
strong attenuation or extinction of PTZ-induced fos expression in
the developing brain (Table 1 and supplementary material Table
S1). These compounds included several natural and synthetic
steroids, as well as steroid-related compounds and compounds
known to interact with other types of nuclear hormone receptors.
Other molecules with known antifungal, anti-inflammatory,
antioxidant, vasodilatory, pesticide, herbicide or neuroactive
properties were also identified. Three structurally related
antifungal agents, sulconazole, bifonazole and oxiconazole, were
identified among the 46 hits, along with three calcium channel
blockers and two inhibitors of monoamine receptors. However,
the mechanisms of action of many of the identified compounds
are unknown. A subset of 12 compounds was then selected from
the initial list of 46 putative anti-convulsants for in-depth analysis
of their dose-response characteristics in the fos expression assay
and the locomotor activity assay. These compounds were initially
selected on the basis of their relatively high potency in suppressing
fos expression, viability of embryos exposed to compound at 10
M, and their availability from suppliers other than the source of
the compound library. Six of these compounds are known to act
on the endocrine or nervous systems and include the steroids
ethinyl estradiol and allopregnanolone, the calcium channel
inhibitors nimodipine and nitrendipine, and the monoamine
receptor inhibitors methiothepin and pimozide. The other six
compounds, which were selected for further evaluation on the
basis of their apparent potency in the initial screen and their
structural diversity, were sulconazole, suloctidil, nerolidol,
dioxybenzone, hexylresorcinol and retinyl acetate. Figs 4 and 5
show that each of these compounds suppressed PTZ-induced fos
expression in 50 hpf embryos. Moreover, all compounds apart from
retinyl acetate exhibited a graded, concentration-dependent
inhibition of locomotor activity in the Viewpoint tracking assay
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Fig. 2. Pentylenetetrazole and picrotoxin treatments induce expression of the synaptic-activity-regulated gene fos in 2-day-old zebrafish embryos, and
this expression is suppressed by the anticonvulsant drug VPA. (A)Treatment of 50 hpf embryos with the GABAA receptor inhibitors PTZ (20 mM) or picrotoxin
(300M) caused rapid induction of fos expression in the forebrain within 30 minutes of addition of drug, which was increased at 60 and 90 minutes after initial
addition. Treatment of 50 hpf embryos with PTZ (20 mM) also induced strong fos expression in the trunk muscle after 30, 60 and 90 minutes of treatment,
whereas treatment with picrotoxin (300M) only induced detectable fos expression after 90 minutes of treatment. (B)PTZ-induced expression of fos in the
developing CNS is greatest in the ventral telencephalon (subpallium; arrows) and ventral diencephalon (arrowheads) within the forebrain of 50 hpf embryos. In
the ventral diencephalon, the fos expression domain induced by PTZ encompasses the preoptic area, posterior tuberculum and hypothalamus. (C)Treatment of
embryos with the anticonvulsant VPA suppresses PTZ- and picrotoxin-induced expression of fos in the ventral telencephalon and ventral diencephalon. 50 hpf
embryos were incubated for 60 minutes in E3 medium containing 1 mM VPA or E3 medium only (no VPA), after which either 20 mM PTZ (+PTZ) or 300M
picrotoxin (+Picrotoxin) was added and embryos were incubated for a further 90 minutes. Embryos were then fixed and analysed for expression of fos transcripts.
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(Figs 4, 5), which was confirmed by quantitative analysis of
locomotor activity (Fig. 6). The most potent anticonvulsants
identified in this screen are ethinyl estradiol, sulconazole, suloctidil,
nerolidol, dioxybenzone and hexylresorcinol. Each of these
compounds exhibited comparable potency at 8.2 M to treatment
of embryos with the clinically prescribed anti-epileptic drug VPA
at a concentration of 1 mM. When the effect of each compound
on apoptosis was evaluated, none induced appreciable cell death
(supplementary material Fig. S1), confirming that the relatively
brief exposure to these compounds did not elicit any significant
cell toxicity. To determine whether the identified compounds
might impair the general viability of larvae, cardiac function of
larvae was monitored after 90 minutes of exposure to each
compound at 8.2 M and 24.7 M (Table 2). At 24.7 M,
nimodipine, pimozide, nitrendipine, sulconazole and suloctidil
caused a slowing of the heart rate, and nimodipine and pimozide
elicited cardiac arrest in a proportion of treated larvae. However,
only nimodipine appreciably inhibited cardiac function when
assayed at a concentration of 8.2 M, causing a slowing of heart
rate (but not cardiac arrest) in treated larvae. Taken together, our
results demonstrate that the use of an in situ hybridisation screen
for fos expression is an efficient route to identifying compounds
with potent in vivo anti-convulsant activities.
DISCUSSION
We sought to develop a zebrafish model of epileptic seizures that
would be amenable to efficient screening of chemical libraries for
compounds with anticonvulsant activities. We found that exposure
of 2-day-old zebrafish embryos to the convulsant PTZ rapidly
induced intense neuromuscular activity, increased locomotor
behaviour and initiated a programme of synaptic-activity-induced
gene expression in specific regions of the brain, all of which are
characteristics of seizures in mammals. The widespread expression
of gabra1 and gabrg2 in the brain of 2-day-old zebrafish embryos,
together with our observation that a second, structurally distinct
GABA pathway inhibitor, picrotoxin, induced a pattern of fos
transcription in the CNS and trunk muscle that is similar to that
induced by PTZ, further suggested that the effects of PTZ in the
embryo are probably mediated by inhibition of the GABA pathway.
Our results are consistent with previous observations of the seizure-
inducing effects of PTZ on 7-day-old zebrafish larvae, which can
be suppressed by a wide variety of known antiepileptic drugs
(Baraban et al., 2005; Berghmans et al., 2007). The induction of fos
transcription in response to excitatory neurotransmission,
particularly as an indicator of seizure onset, has been documented
extensively in mammals and in 7 dpf larval zebrafish, but we show
here for the first time that the PTZ-induced fos expression pattern
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Fig. 3. Increased expression of CNS-specific genes accompanies
transcriptional activation of fos by pentylenetetrazole. Exposure of 50 hpf
embryos to 20 mM PTZ induced expression of genes encoding the
transcription factor Npas4 and the secreted neurotrophic factor Bdnf in the
ventral forebrain, both of which are known to be synaptic-activity-regulated,
within 90 minutes of exposure. Expression of fos in the CNS was strongest in
the regions of the forebrain that also expressed npas4 and bdnf. Increased
expression of pyya, encoding a homologue of Neuropeptide Y, was also
observed at multiple locations within the CNS, most prominently within the
posterior hindbrain. Left panels, embryos incubated in E3 medium only; right
panels, embryos incubated in E3 medium containing 20 mM PTZ for 90
minutes.
Table 1. Identification of compounds that suppress PTZ-induced 
expression of fos in 50 hpf zebrafish embryos 
Sub-group Compounds 
Steroid/steroid-like Megestrol acetate, ethinylestradiol, 
epiandrosterone, progesterone, 
allopregnanolone, formestane, 
hexestrol (related to 
diethylstilbestrol), triptophenolide 
Non-steroidal nuclear receptor 
ligand 
Gemfibrozil, retinyl acetate 
Anti-infective Sulconazole, bifonazole, 
oxiconazole, acrisorcin, fenamisal, 
hexylresorcinol, diallyl sulphide, 
exalamide 
Anti-inflammatory Naproxen, mefenamic acid 
Calcium channel blocker Nimodipine, nitrendipine, suloctidil 
Monoamine receptor ligand Methiothepin maleate, pimozide 
Antioxidant Theaflavin monogallates, 2-
isopropyl-methoxycinnamic acid 
Vasodilator Molsidomine 
Pesticide/herbicide Lindane, deguelin, rotenonic acid, 
endrin, propanil 
Mechanism of action unknown Mundulone, dioxybenzone, 
nonoxynol-9, larixol, 
haematommic acid, avocadyne, 
ethyl everninate, isosafrole, 
oxyquinoline hemisulphate, 8- -
hydroxycarapin 3,8-hemiacetal, 
peucedanin, nerolidol, 
senecrassidiol 6-acetate 
46 compounds were identified from the Spectrum Collection of 2000 bioactive small 
molecules, each of which strongly suppressed PTZ-induced expression of fos in 2-day-
old zebrafish embryos. Compounds were classified into sub-groups as indicated in the 
table. 
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Fig. 4. Identification of known neuroactive compounds with anticonvulsant activity in the zebrafish embryo. Known inhibitors of neural activity were
identified within the Microsource Spectrum Collection on the basis of their concentration-dependent suppression of PTZ-induced fos expression and inhibition
of PTZ-induced locomotor activity. Compounds were administered to 50 hpf embryos for 90 minutes in 96-well plates, at a final concentration of 0.9, 2.7, 8.2, 24.7
or 74.1M (as indicated), then 20 mM PTZ was added and embryos were incubated for a further 60 minutes, before being fixed and analysed for expression of
fos. In parallel, 4-day-old zebrafish larvae were exposed to the same range of compound concentrations in 48-well plates for 90 minutes, then PTZ was added
and larvae were incubated for a further 10 minutes. 48-well plates were then transferred to the Viewpoint Zebrabox for live tracking of locomotor activity over a
10 minute period. Black, green and red traces indicate swimming speeds of 0-1.5, 1.5-6 and >6 mm/second, respectively. (A)Ethinylestradiol; (B)
allopregnanolone; (C) nimodipine; (D) nitrendipine; (E) methiothepin; (F) pimozide. (G)The anticonvulsant activity of the positive control compound VPA is
shown, for comparison.
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in 50 hpf embryos is complex even at this relatively early stage, and
includes several spatially distinct structures within the brain. In
rodents, transcription of fos is induced by convulsants such as kainic
acid and in response to a range of other excitatory stimuli, including
anxiogenic or addictive compounds, as well as behavioural stimuli
such as fear-inducing or other stressful experiences. Because fos is
such a versatile marker of synaptic activity in the mammalian CNS,
it will be of interest to explore further its responsiveness to a similar
range of stimuli in zebrafish. The recent identification of a large
number of synaptic-activity-regulated genes raises the possibility
that some of these genes are specifically activated in distinct
neuronal subsets by distinct neurotransmitter subtypes (Loebrich
and Nedivi, 2009). Such markers might also be useful in
distinguishing different types of neuroactive drugs, e.g.
psychostimulants and convulsants, through their effects on
regulating the activity of distinct neuronal subtypes. Genetic analysis
of fos function in the mouse indicates that this gene performs a
neuroprotective role as part of the response to the onset of seizures
(Zhang et al., 2002), although the relevant downstream target genes
for the Fos transcription factor, and its mechanism of action,
remain unidentified. The dramatic induction of fos transcription in
the embryonic trunk muscle was surprising and has not previously
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Fig. 5. Identification of compounds with anticonvulsant activity in the zebrafish embryo. Previously unknown inhibitors of neural activity were identified
within the Microsource Spectrum Collection, on the basis of their concentration-dependent suppression of PTZ-induced fos expression and inhibition of PTZ-
induced locomotor activity. Compounds were administered to embryos for 90 minutes in 96-well plates, at a final concentration of 0.9, 2.7, 8.2, 24.7 or 74.1M
(as indicated), then 20 mM PTZ was added, and embryos were then incubated for a further 60 minutes before being fixed and analysed for expression of fos. In
parallel, 4-day-old zebrafish larvae were exposed to the same range of compound concentrations in 48-well plates for 90 minutes, then PTZ was added and
larvae were incubated for a further 10 minutes. 48-well plates were then transferred to the Viewpoint Zebrabox for live tracking of locomotor activity over a 10
minute period. Black, green and red traces indicate swimming speeds of 0-1.5, 1.5-6 and >6 mm/second, respectively. (A)Sulconazole; (B) suloctidil; (C) nerolidol;
(D) dioxybenzone; (E) hexylresorcinol; (F) retinyl acetate.
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been documented as a response to seizures. This abundant
transcription of fos within the developing somites of convulsant-
treated embryos could indicate a protective function for this gene
in muscle cells, which might help to buffer these cells against the
potentially damaging effects of the strong calcium influx that occurs
during seizures. Our use of a muscle-specific GCaMP-3 transgene
revealed that convulsant-induced calcium-influx-dependent
increases in fluorescence could be readily detected in muscle cells
within 5 minutes of PTZ administration, and suggests that
measurement of GCaMP-3 fluorescence could provide the basis for
a high-throughput in vivo screen for detecting anticonvulsant
activities in the future. Equally, in situ hybridisation assays to detect
fos and other gene expression, or quantitative analysis of fluorescence
changes using a GCaMP-3 transgenic line, could be used for the
efficient detection of seizure liabilities in compounds as part of safety
pharmacology programmes (Winter et al., 2008).
In neurons, the onset of synaptic activity induces transcription
of a specific set of genes encoding transcription factors, intercellular
signalling molecules and peptide hormones (Loebrich and Nedivi,
2009). To date, fos is perhaps the best characterised of these
synaptic-activity-regulated genes. We found that genes encoding
the bHLH transcription factor Npas4, the secreted intercellular
signal Bdnf and the stress hormone PYYa exhibited increased
transcription in the CNS of PTZ-treated embryos. Npas4 has
previously been shown to promote the formation of GABAergic
inhibitory synapses in mammalian cultured neurons (Lin et al.,
2008), so its induction within the ventral forebrain of PTZ-treated
embryos could reflect the activation of inhibitory neural circuits
within this region to mitigate the excitatory effects of PTZ exposure.
The neuroprotective properties of Bdnf include roles in protecting
neurons against axonal injury and apoptosis, as well as in facilitating
experience-dependent synaptic remodelling and promoting
neurogenesis (Lipsky and Marini, 2007). We also observed that PTZ
exposure led to increased expression of pyya, a close relative of
NPY, which has been implicated both as an endogenous inhibitor
of epileptic seizures (Baraban et al., 1997) and as a neuroprotective
component of the endocrine response to stress and mood disorders,
mediating anxiolytic effects on neuronal targets within the
mammalian CNS (Heilig, 2004; Thorsell, 2010). The complexity of
the fos expression pattern induced by PTZ treatment suggests that
transcription of fos is activated in many different types of neurons
within the CNS. PTZ-induced expression of fos is most prominent
in the ventral telencephalon and ventral diencephalon, as is
expression of npas4 and bdnf, suggesting that neurons within these
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Fig. 6. Quantitative comparison of the concentration-dependent effects of identified anticonvulsants on PTZ-induced locomotor activity of 4-day-old
zebrafish larvae. Compounds were administered to larvae for 90 minutes in 48-well plates, at a final concentration of 2.7, 8.2 or 24.7M, then 20 mM PTZ was
added and larvae were then incubated for a further 10 minutes before being transferred to the Viewpoint Zebrabox for live tracking of locomotor activity over a
10 minute period. For each test compound, n9; for VPA controls (V), n71; for PTZ controls (P), n108; for E3-only controls (E), n96. Error bars show s.e.m.
Asterisks indicate values that are significantly different from the value for PTZ-treated embryos (P), using a one-way ANOVA analysis with Dunnett’s post-test.
Level of statistical significance is indicated: ***P<0.001; **P<0.01; *P<0.05.
D
ise
as
e 
M
od
el
s &
 M
ec
ha
ni
sm
s  
    
   D
M
M
regions are particularly sensitive to loss of GABA-mediated
inhibitory neurotransmission. It is interesting to note that, in
mammals, the ventral telencephalon and ventral diencephalon give
rise to components of the limbic system and hypothalamic-
pituitary-adrenal (HPA) axis, respectively, which mediate neural
and endocrine responses to behavioural and pharmacological
stressors, including factors that trigger the onset of seizures. Future
studies will explore the possibility that GABAergic neurons lying
within embryonic precursors of the limbic system and HPA axis
regulate susceptibility to seizures. Phenotypic analysis of zebrafish
mind bomb mutant embryos, which lack Notch signalling pathway
activity, previously demonstrated that expression levels of fos, bdnf
and pyya transcripts were increased in the CNS of 3-day-old mutant
embryos, which also exhibit spontaneous seizures (Hortopan et al.,
2010a). In light of the phenotypic similarities between PTZ-treated
wild-type embryos and mind bomb mutants, it might be of interest
to examine the possibility that Notch pathway activity regulates
GABAergic signalling. The ease with which PTZ-induced
expression of fos was detected in a specific pattern within the
zebrafish embryonic brain, together with its robust inhibition by
exposure of embryos to VPA, suggested that suppression of PTZ-
induced fos transcription in 2-day-old embryos could provide a
means for identifying putative anticonvulsants in chemical libraries.
Our results demonstrate the validity of this approach, in which a
hit rate of 2.3% was observed. The two largest classes of compounds
that exhibited anticonvulsant activity were steroids and anti-
infectives (Table 1). Among the steroids with anticonvulsant
activity, progesterone and its derivatives allopregnanolone and
megestrol were identified, as were the weak androgens
epiandrosterone and formestane. In addition, the synthetic
estrogens ethinyl estradiol and hexestrol exhibited robust
anticonvulsant activities. Epiandrosterone is an isomer of the
known anticonvulsant androsterone (Kaminski et al., 2005),
whereas megestrol was previously shown to be neuroprotective
against oxidative stress (Sarang et al., 2002). Endogenous
neurosteroids such as allopregnanolone and progesterone have
previously been demonstrated to exhibit potent anticonvulsant
activities in rodent models, and evidence suggests that circulating
neurosteroids regulate seizure frequency and severity in some
individuals with epilepsy (Reddy, 2010; Pack et al., 2011).
Allopregnanolone functions as a direct allosteric agonist of the
GABAA receptor, suppressing seizures by potentiating the receptor’s
signalling function and thereby over-riding the inhibitory effects
of PTZ (Hosie et al., 2006). Progesterone could exert its
anticonvulsant effect in the zebrafish embryo as a result of its
conversion to allopregnanolone, as has been observed in mice
(Reddy et al., 2004). Our discovery of an anticonvulsant effect for
ethinyl estradiol is intriguing because this drug is known to reduce
aggression and reproductive success in zebrafish (Colman et al.,
2009) and it is neuroprotective against kainic-acid-induced
excitotoxicity (Picazo et al., 2010), but it has not previously been
shown to stimulate inhibitory neurotransmission as a GABAA
receptor agonist or to act as an anticonvulsant. Nevertheless, ethinyl
estradiol was a more potent inhibitor of PTZ-induced locomotor
activity than was allopregnanolone, raising the possibility that it
might have an inhibitory effect on movement that could be
independent of, and in addition to, an interaction with the GABAA
receptor. Three calcium channel blockers, nimodipine, nitrendipine
and suloctidil, were identified as potent inhibitors both of PTZ-
induced fos expression and locomotor activity, perhaps reflecting
their abilities to directly inhibit neural activity and muscular
contraction by blocking calcium influx. Exposure to nimodipine
(24.7 M) caused cessation of heartbeat in a proportion (~33-36%)
of treated embryos (Table 2). This effect might be due to inhibition
of calcium channel function in cardiomyocytes, rather than a non-
specific effect on cell viability, because no increase in apoptosis
was observed after exposure to this compound. The identification
of the antipsychotics methiothepin and pimozide, both of which
inhibit dopamine and serotonin receptors (Seeman, 2002; Mahé et
al., 2004), as suppressors of PTZ-induced fos expression and
locomotor activity, is particularly interesting and strongly suggests
that, as observed in other organisms (Bozzi et al., 2011), these
monoamine neurotransmitters are involved in regulating seizures
in zebrafish.
The second largest group of functionally related compounds that
we identified in our screen was a class of anti-infectives that includes
sulconazole, bifonazole and oxiconazole. Each of these compounds
contains an imidazole ring and is related to ketoconazole, which is
used to suppress excess glucocorticoid production in people with
Cushing’s syndrome, in which activity of the HPA axis is abnormally
high (Feldman, 1986). The mode of action of ketoconazole involves
inhibition of stress hormone synthesis, by an incompletely
understood mechanism, raising the possibility that its close relatives
might also act similarly, modulating neuroendocrine components of
the HPA axis that regulate stress responses and thereby suppressing
seizures. Interestingly, the imidazole-based anti-epileptic drugs
denzimol and nafimidone inhibit sodium channels (Mishra and
Ganguly, 2012), suggesting another mechanism by which sulconazole,
bifonazole and oxiconazole could elicit their anticonvulsant effects.
Two other anti-infective hits identified in our screen are
hexylresorcinol and acrisorcin (which is a combination of 9-
aminoacridine and hexylresorcinol). Hexylresorcinol has anaesthetic
properties and was previously shown to bind to sodium channels,
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Table 2. Effects of exposure to fos-suppressor compounds on 
viability of 4-day-old larvae 
  % with heartbeat 
Compound 8.2 M 24.7 M 
Sulconazole 100 100 S 
Suloctidil 100 100 S 
Ethinyl estradiol 100 100 
Nimodipine 100 S 66 S 
Nerolidol 100 100  
Allopregnanolone 100 100 
Dioxybenzone 100 100 
Hexylresorcinol 100 100 
Methiothepin 100 100 
Nitrendipine 100 100 S 
Pimozide 100 44 S 
Retinyl acetate 100 100 
Larvae were exposed to each identified fos-suppressor compound at a concentration 
of either 8.2 µM or 24.7 µM for 90 minutes, after which the number of larvae with a 
regular heartbeat was determined. For each treatment, a total of nine larvae were 
tested. Treatments that slowed the heartbeat of larvae in comparison with the 
untreated larvae are indicated by S. 
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inhibiting their function (Buchholtz et al., 2009), which could account
for its anticonvulsant effect in our experiments. Several other
compounds identified in our screen exhibit anticonvulsant activity
in rodents. Previous studies of the COX inhibitors naproxen and
mefenamic acid revealed that they both possessed anticonvulsant or
related activities in PTZ-treated mice (Dhir et al., 2005; Wallenstein,
1991). Moreover, mefenamic acid acts as an agonist of the GABAA
receptor (Coyne et al., 2007). Interestingly, molsidomine enhanced
the anticonvulsant properties of VPA in PTZ-treated mice (Tutka et
al., 2002), and peucedanin is closely related to oxypeucedanin, which
exhibited anticonvulsant activity in electroshock-treated mice
(Luszczki et al., 2010). Among the compounds identified in our
screen, the flavonoids rotenonic acid and deguelin, as well as the
organochlorines endrin, propanil and lindane, were identified as
anticonvulsants. Given that each of these compounds has a history
of use as a neurotoxic pesticide, it is perhaps unsurprising that they
were identified in our screen for neuroactive anticonvulsants using
a gene expression assay for synaptic activity. Interestingly, lindane is
a direct inhibitor of GABAA receptors and exhibits convulsant activity
in mice (Tochman et al., 2000; Vale et al., 2003), so its ability to
suppress fos expression might reflect neurotoxicity, rather than an
intrinsic anticonvulsant activity.
Overall, our results describe the establishment and validation of
an in vivo model of epileptic seizures in the 2-day-old zebrafish
embryo and its utilisation in a re-profiling screen of a bioactive
small molecule library to identify compounds with anticonvulsant
properties. Some of the compounds identified in this screen, such
as allopregnanolone, nitrendipine, nimodipine, pimozide and
methiothepin, have known biochemical specificities that readily
account for their anticonvulsant behaviour in our assays. By
contrast, the mechanisms of action of sulconazole, suloctidil and
hexylresorcinol are poorly understood, and those of dioxybenzone
and the sesquiterpene nerolidol are completely unknown. These
compounds thus represent novel starting points for the
development of new anti-epileptic drugs. Future studies will aim
to elucidate the mechanisms of action of these molecules and to
employ the in vivo assays we have developed to identify further
compounds with anticonvulsant properties.
METHODS
Pharmacological induction and suppression of seizures in
zebrafish embryos
Stocks of PTZ (200 mM, in water) or picrotoxin (100 mM in DMSO)
were diluted to the required concentration in fresh E3 medium.
Embryos were exposed to PTZ or picrotoxin then analysed as
required. For in situ hybridisation analysis, embryos were transferred
immediately to fixative containing 4% paraformaldehyde and
incubated at 4oC overnight. As a positive control for anticonvulsant
activity, a 250 mM stock of VPA was made up in E3 medium and
administered to embryos at a final concentration of 2.5 mM before
the addition of the convulsant. All procedures involving experimental
animals were performed in compliance with local and national animal
welfare laws, guidelines and policies.
Compound library aliquoting, storage and administration to
embryos
The Spectrum Collection (Microsource Discovery Systems) of 2000
compounds was stored with each compound at a concentration of
5 mM in DMSO in 25 v-bottomed 96-well microtitre plates
(Matrix) at –80°C. Assay plates contained compounds diluted to
10 M in E3 media for drug screening. For the anticonvulsant assay,
embryos were raised to 50 hpf and treated with Pronase (Sigma)
to remove the chorions. Embryos were aliquoted at four embryos
per well into Multiscreen mesh-bottomed plates (100 mm;
Millipore) and transferred to Multiscreen 96-well culture receiver
trays (Millipore) containing the Spectrum library compounds at
10 M in columns 2-11, with control wells containing either 1 mM
VPA, E3 or DMSO only in columns 1 and 12. Assay plates were
incubated in the dark at 28°C for 90 minutes followed by addition
of PTZ to a final concentration of 20 mM to all the compound
wells and half of the control wells. Assay plates were incubated for
1 hour at 28°C and the embryos were then transferred to fixative
containing 4% PFA and stored at 4°C overnight. Embryos were
bleached according to the standard protocol (Thisse and Thisse,
2008) and stored at –20°C in methanol until required for in situ
hybridisation. In order to facilitate screening and eliminate the need
to transfer embryos between plates at any stage of the process,
samples were maintained in the same 96-well mesh-bottomed
Multiscreen plates (Millipore) during drug treatment, in situ
hybridisation and hit detection. Hits that were identified in the
primary screen were selected from the Spectrum library and
rescreened using the method above. Selected compound stocks
were then purchased separately from Sigma and tested in dose-
response assays to confirm that the Spectrum Collection stocks
had been assigned the correct identities.
Whole-mount in situ hybridisation analysis of gene expression
Digoxigenin-labelled RNA probes were prepared as recommended
by the manufacturer (Roche). Details of the gabra1, gabrg2, fos,
npas4, bdnf and pyya probes utilised are available on request.
Whole-mount in situ hybridisation was performed using standard
procedures (Thisse and Thisse, 2008) with modifications. All steps
were performed using Multiscreen mesh-bottomed plates. In order
to increase throughput, the Biolane HTI 16V In situ robot (Intavis)
was used. Stained embryos were imaged in Multiscreen plates using
a Nikon AZ100 microscope fitted with an automated stage (Prior).
Extended depth of focus (EDF) images from z-sections through
the embryos were compressed using the NIS-Elements software
(Nikon) to show the areas of staining and the results were scored.
Wells that contained embryos with no fos expression in the brain
were taken forward for further analysis.
Analysis of locomotor activity using the Viewpoint Zebrabox
system
The distance moved by larvae over a 10 minute period was
recorded using the Zebrabox system (Viewpoint, France). AB larvae
at 4 dpf, with swim bladders inflated, were transferred to a 48-well
microtitre plate, one larva per well in 445 l of E3 medium.
Dilutions of compounds over the range of 74-0.3 M were added
to embryos in triplicate, and control wells containing VPA and E3
alone were also included. Plates were incubated at 28°C in the dark
for 90 minutes. Larvae were then tested for the presence of a
heartbeat and motor response before addition of PTZ to wells
containing compounds and half of the wells containing E3 only.
After 5 minutes exposure to PTZ, larval movements were recorded
with the Zebrabox for 10 minutes using a light cycle of 2
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minutes:100% light; 2 minutes:0% light. Each experiment was
repeated in triplicate to give nine data points for every drug
concentration and the total distance moved by each larva was
calculated.
Statistical analysis of locomotor activity data
For each group of embryos exposed to compounds, the mean
distance moved and the standard error of mean (s.e.m.) were
calculated. The effects on locomotor activity of exposing embryos
to a range of PTZ concentrations were evaluated using a one-way
ANOVA with Dunnett’s post-test. The effects of administering hit
compounds were also evaluated using a one-way ANOVA statistical
test to determine whether each compound suppressed PTZ-
induced locomotor activity at 3, 8 and 24 M concentrations.
Analysis of GCaMP-3 fluorescence in muscle cells of PTZ-treated
embryos
A muscle-specific GCaMP-3 reporter plasmid was constructed by
inserting the GCaMP-3 open reading frame (Tian et al., 2009)
downstream of zebrafish mylz2 promoter sequences (von Hofsten
et al., 2008). The circular plasmid DNA was injected into zebrafish
embryos at the one-cell stage at a concentration of 0.1 ng/nl to
generate mosaic embryos, which were incubated at 28.5°C until
they reached 50 hpf. Embryos with detectable GFP fluorescence
in muscle cells were transferred to E3 medium containing
blebbistatin (50 M) for 30-60 minutes at 28.5°C. Embryos were
transferred singly to a 35 mm Wilco glass-bottomed Petri dish (22
mm glass diameter) and mounted for lateral viewing in a drop of
1% low-melting-point agarose containing 50 M blebbistatin and
20 mM PTZ. Convulsant-induced increases in GCaMP-3
fluorescence were apparent within 3-5 minutes after mounting, and
embryos were imaged with a Perkin-Elmer Spinning Disk
microscope and Volocity (Improvision) software, using the GFP
channel and a frame-rate of 20-40 Hz.
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TRANSLATIONAL IMPACT
Clinical issue
Epilepsy is a common neurological disorder affecting ~1% of the world’s
population. People with epilepsy experience seizures that vary in severity,
frequency and physical location in the nervous system. A range of genetic
factors play important etiologic roles in many forms of epilepsy, reflecting the
heterogeneity of the pathogenetic mechanisms that underlie these disorders.
Various structurally diverse anti-epileptic drugs are available for the treatment
of epilepsy, but ~30% of people with epilepsy do not respond satisfactorily to
many of the first-line treatments, and substantial side effects are widely
documented. Thus, there is a large unmet clinical need for new anti-epileptic
medicines with improved specificity and potency, and with new mechanisms
of action. Recent progress in identifying new drugs has been slow, at least in
part because high-throughput methods for in vivo discovery of new drugs
with anti-convulsant activity are limited. 
Results
Taking advantage of the transparency and developmental simplicity of the 2-
day-old zebrafish embryo, the authors developed and validated a tractable, in
vivo, high-throughput assay based on expression of fos, which is upregulated
in response to chemically induced seizures. They applied this assay in a screen
of 2000 bioactive small molecules and identified 46 compounds with anti-
convulsant activity. Further analysis of a subset of these compounds, which
included both known and newly identified anticonvulsants, showed that they
exhibited concentration-dependent inhibition of convulsant-induced
locomotor activity and fos transcription in 2-day-old zebrafish embryos. 
Implications and future directions
These data introduce a robust, scaleable approach for in vivo screening for
compounds with anti-convulsant activity in a vertebrate model organism, and
show how it can be used it to identify anti-convulsants from a library of small
molecules. This strategy provides a relatively low-cost, high-throughput route
to discovering new molecules with potential clinical application for the
treatment of epilepsy
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